Difference between revisions of "Team:Marburg/Design"

Line 71: Line 71:
 
margin-left: -40px !important;
 
margin-left: -40px !important;
 
}
 
}
 +
}
 +
 +
p a {
 +
padding: 0 !important;
 
}
 
}
 
</style>
 
</style>
Line 255: Line 259:
 
</div>
 
</div>
 
<div class="wrap-collabsible">
 
<div class="wrap-collabsible">
<input id="collapsible2" class="toggle" type="checkbox">
+
<input id="collapsible2" class="toggle" type="checkbox">
<label for="collapsible2" class="lbl-toggle">CRISPR gene editing</label>
+
<label for="collapsible2" class="lbl-toggle">CRISPR gene editing</label>
<div class="collapsible-content">
+
<div class="collapsible-content">
<div class="content-inner">
+
<div class="content-inner">
<p>
+
<p>
<u>CRISPR gene editing)</u><br>
+
CRISPR/Cas systems are powerful tools that have gained a lot of popularity in the recent years.
CRISPR/Cas systems are powerful tools that have gained a lot of popularity in the recent years.
+
As they can be used for a wide array of applications - like the integration of whole genes,
As they can be used for a wide array of applications - like the integration of whole genes, alteration of single
+
alteration of single nucleotides, knock-outs of whole genetic regions, as well as the use of the
nucleotides, knock-outs of whole genetic regions, as well as the use of the DNA-binding property in a multitude
+
DNA-binding property in a multitude of applications through so called deadCas systems, where the
of applications through so called deadCas systems, where the Cas protein does not exhibit nuclease activity
+
Cas protein does not exhibit nuclease activity
<a href=https://www.cell.com/action/showPdf?pii=S0092-8674%2814%2900604-7> (Hsuet al., 2014) </a> - we were
+
<a href="https://www.cell.com/action/showPdf?pii=S0092-8674%2814%2900604-7">(Hsuet al., 2014)</a>
eager to implement such a system into our own <a href="https://2019.igem.org/Team:Marburg/Design">toolbox</a>.
+
- we were eager to implement such a system into our own
Diving into the literature we noticed many different systems are available,the most commonly used one being
+
<a href="https://2019.igem.org/Team:Marburg/Design">toolbox</a>. Diving into the literature we
CRISPR/Cas9, and we began to wonder which of them we should use.
+
noticed many different systems are available,the most commonly used one being CRISPR/Cas9, and we
<br>
+
began to wonder which of them we should use.<br>
In our <a href="https://2019.igem.org/Team:Marburg/Description">description</a> we presented CRISPR/Cas9 and CRISPR/Cas12a,
+
In our <a href="https://2019.igem.org/Team:Marburg/Description">description</a> we presented
showing the
+
CRISPR/Cas9 and CRISPR/Cas12a, showing the differences of these two systems. Looking deeper into
differences of these two systems. Looking deeper into CRISPR/Cas12a we noticed a few advantages that finally
+
CRISPR/Cas12a we noticed a few advantages that finally led us to choose it as our preferred
led us to choose it as our preferred system.
+
system.<br>
 
+
As the sgRNA used as a guide for Cas9 is usually ~100nt long, chemical synthesis is more complex
As the sgRNA used as a guide for Cas9 is usually ~100nt long, chemical synthesis is more complex and
+
and expensive in comparison to the ~43nt needed for the Cas12a guiding crRNA
expensive in comparison to the ~43nt needed for the Cas12a guiding crRNA <a
+
<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481">(Swarts and Jinek, 2018)</a>
href=https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481> (Swarts and Jinek, 2018) </a> - an
+
- an unpleasant fact, especially for iGEM teams that do not have many resources available to them,
unpleasant fact, especially for iGEM teams that do not have many resources available to them, but the
+
but the main reasons we chose Cas12a are others. Multiplexed gene editing is one of the key
main reasons we chose Cas12a are others. Multiplexed gene editing is one of the key features of these
+
features of these CRISPR/Cas systems, but how to actually apply it differs:<br>
CRISPR/Cas systems, but how to actually apply it differs: <br>
+
For Cas9 each sgRNA is in need of its own promoter, which means that they have to be expressed
For Cas9 each sgRNA is in need of its own promoter, which means that they have to be expressed from
+
from different vectors or a multi cassette vector (
different vectors or a multi cassette vector ( <a
+
<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0058">X. Ma et
href=https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0058> X. Ma et al.,
+
al., 2015</a>;
2015 </a> ; <a href=https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0104> Z.
+
<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0104"> Z. Zhang
Zhang et al., 2016 </a> ). In contrary, multiplexed genome editing with Cas12a can be achieved
+
et al., 2016 </a> ). In contrary, multiplexed genome editing with Cas12a can be achieved simply
simply by expressing all of the needed guide RNAs in one transcriptional unit, where they are then
+
by expressing all of the needed guide RNAs in one transcriptional unit, where they are then
processed into different crRNAs by Cas12a <a
+
processed into different crRNAs by Cas12a
href=https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0065> (Kim, et al.,
+
<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0065">(Kim, et
2016; Nishimasu et al., 2017) </a> . This is a huge advantage of Cas12a. Furthermore, CRISPR/Cas9
+
al., 2016; Nishimasu et al., 2017)</a>. This is a huge advantage of Cas12a. Furthermore,
was shown to be toxic in cyanobacteria <a
+
CRISPR/Cas9 was shown to be toxic in cyanobacteria
href=https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-016-0514-7> (Wendt et
+
<a href="https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-016-0514-7">
al., 2016) </a>, which is one of the foremost reasons CRISPR technologies have not been widely
+
(Wendt et al., 2016)</a>, which is one of the foremost reasons CRISPR technologies have not been
applied in cyanobacteria - the usage of Cas12a though, does not seem to have the same toxicity <a
+
widely applied in cyanobacteria - the usage of Cas12a though, does not seem to have the same
href=https://www.nature.com/articles/srep39681> Ungerer and Pakrasi, 2016 </a> , making it the ideal
+
toxicity <a href="https://www.nature.com/articles/srep39681"> Ungerer and Pakrasi, 2016 </a>,
candidate for the Green Extension of the <a href="https://2019.igem.org/Team:Marburg/Parts">Marburg Collection</a>.
+
making it the ideal candidate for the Green Extension of the
<br>
+
<a href="https://2019.igem.org/Team:Marburg/Parts">Marburg Collection</a>.<br>
 
+
The actual implementation of the CRISPR/Cas12a system into our toolbox necessitated a well thought
The actual implementation of the CRISPR/Cas12a system into our toolbox necessitated a well thought
+
out plan. The design of our CRISPR/Cas12a system was mainly affected by the fact that we wanted to
out plan.
+
have a convenient and rapid tool for genomic manipulation. The lvl 0 part (What are parts? Read
The design of our CRISPR/Cas12a system was mainly affected by the fact that we wanted to have a
+
more about it click <a href="https://2019.igem.org/Team:Marburg/Basic_Part">here!</a>) of the
convenient and rapid tool for genomic manipulation.
+
Cas12a protein was created via PCR amplification from the plasmid pSL2680, but special overhangs
The lvl 0 part (What are parts? Read more about it click <a href="https://2019.igem.org/Team:Marburg/Basic_Part">here!</a>) of the Cas12a protein was created via PCR amplification from the plasmid
+
were added in order to clone the PCR product into a lvl 0 acceptor vector. The part was introduced
pSL2680, but special overhangs were added in order to clone the PCR product into a lvl 0
+
as a coding sequence (CDS) part in the MoClo standard to be included in the Green Expansion of the
acceptor vector. The part was introduced as a coding sequence (CDS) part in the MoClo
+
Marburg Collection. The lvl 1 part of the Cas12a protein was equipped with a rather weak promoter
standard to be included in the Green Expansion of the Marburg Collection. The lvl 1 part of
+
so that the toxicity caused by overproduction of the endonuclease could be kept low. The parts
the Cas12a protein was equipped with a rather weak promoter so that the toxicity caused by
+
used for lvl 1 assembly were: pMC0_1_03 + pMC0_2_03 + pMC0_3_07 + pMC0_4_33 + pMC0_5_07 +
overproduction of the endonuclease could be kept low. The parts used for lvl 1 assembly
+
pMC0_6_17. For the construction of the crRNA part the design of the plasmid pSL2680 was mainly
were: pMC0_1_03 + pMC0_2_03 + pMC0_3_07 + pMC0_4_33 + pMC0_5_07 + pMC0_6_17. For the
+
maintained, but the <i>lacZ</i> cassette was replaced by a GFP cassette to enable easier screening
construction of the crRNA part the design of the plasmid pSL2680 was mainly maintained, but
+
of crRNA assembly and to reduce expenses for X-Gal/IPTG. It was constructed as a part reaching
the <i>lacZ</i> cassette was replaced by a GFP cassette to enable easier screening of crRNA
+
from the RBS site to the end of the terminator site. As the whole system is built for modular
assembly and to
+
cloning in PhytoBrick syntax, it is possible to freely exchange the parts around the Cas12a and
reduce expenses for X-Gal/IPTG. It was constructed as a part reaching from the RBS site to
+
crRNA parts - in this way the amount of crRNA/Cas12a can be controlled by choosing promoters with
the end
+
different strengths.<br>
of the terminator site. As the whole system is built for modular cloning in PhytoBrick
+
Our initial plan was to synthesize the crRNA with the desired overhangs, but as the sequence
syntax, it is possible to freely exchange the parts around the Cas12a and crRNA parts - in
+
contains multiple direct repeats, it was not possible for providers to synthesize this construct,
this way the amount of crRNA/Cas12a can be controlled by choosing promoters with different
+
which is why we split it into four different parts that then had to be assembled. For this
strengths.
+
assembly the four parts were first cloned into the pJET1.2/blunt vector by Thermo Scientific and
 
+
then digested with BsaI while the acceptor vector was digested with BsmBI. In this way the final
Our initial plan was to synthesize the crRNA with the desired overhangs, but as the sequence
+
vector still contains BsaI recognition sites, so that it can be used in a level 1 assembly Golden
contains multiple direct repeats, it was not possible for providers to synthesize this
+
Gate reaction. The cloning of the level 2 part with this crRNA part was done by ending with a
construct, which is why we split it into four different parts that then had to be assembled.
+
ligation step to make sure the GFP dropout remains in the vector.
For this assembly the four parts were first cloned into the pJET1.2/blunt vector by Thermo
+
</p>
Scientific and then digested with BsaI while the acceptor vector was digested with BsmBI. In
+
</div>
this way the final vector still contains BsaI recognition sites, so that it can be used in a
+
</div>
level 1 assembly Golden Gate reaction. The cloning of the level 2 part with this crRNA part
+
</div>
was done by ending with a ligation step to make sure the GFP dropout remains in the vector.
+
</p>
+
 
+
<br>
+
 
+
</div>
+
</div>
+
</div>
+
 
+
 
<div class="wrap-collabsible">
 
<div class="wrap-collabsible">
 
<input id="collapsible3" class="toggle" type="checkbox">
 
<input id="collapsible3" class="toggle" type="checkbox">

Revision as of 18:06, 18 November 2019

D E S I G N


"Always plan ahead. It wasn’t raining when Noah build the ark."
- Richard Cushing

What does expanding the golden gate based Marburg Collection, automating time consuming lab work and establishing the CRISPR/Cpf1 system in Synechococcus elongatus UTEX 2973 have in common?
To achieve these objectives, it is always necessary to have a comprehensive theoretical preparation. It all starts with literature research, summarizing the current state of the art and based on this developing own ideas. To have the theoretical background settled before the lab work starts is a key point of every project and consumes many hours.
Because in the near future phototrophic organisms will get more and more relevance for biotechnological applications, we want to establish the use of Synechococcus elongatus as a phototrophic organism for synthetic biology. Following the principles of synthetic biology to simplify the process of engineering of biological systems, we set it our goal to establish Synechococcus elongatus UTEX 2973 as the fastest and most accessible phototrophic chassis to date, providing it as a wind tunnel for phototrophic organisms with user friendly and standardized workflows.
In order to achieve these goals, a lot of effort has been put into designing, building, testing, evaluating and learning. Further, these steps had to be iterated over and over again to elaborate our standardized designs. By providing you our theoretical background we want to give you an insight in our decision-making.


S T R A I N
E N G I N E E R I N G


We modified Synechococcus elongatus UTEX 2973 to establish the CRISPR/Cpf1 system in our organism.

T O O L B O X


We expanded last years Marburg Collection and made the parts suitable for Synechococcus elongatus UTEX 2973.